Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of Ertapenem in Patients Aged Over 75

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age\> or equal to 75 years~* Treatment with ertapenem (1g daily) for at least 48 hours IV or SC (or one then the other)~* Subject affiliated or beneficiary of a social security system,~* Free Consent, informed and signed by the participant or by the designation of a proxy if delirium and the investigator.~Exclusion Criteria:~* Age \< 75 years~* Criteria for legislation: those under protection of the justice, subject participating in other research, including a period of exclusion still going to pre-inclusion

- Gender: ALL
- Minimum Age: 75 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ertapenem IV (Type: ACTIVE_COMPARATOR): IV administration of ertapenem
- Ertapenem SC (Type: EXPERIMENTAL): SC administration of ertapenem

Based on this trial design, predict the completion outcome and termination type (if applicable).